3 114

Cited 0 times in

Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine

Authors
 Benjamin P. Sablan  ;  Dong Joon Kim  ;  Nina G. Barzaga  ;  Wan Cheng Chow  ;  Mong Cho  ;  Sang Hoon Ahn  ;  Seong Gyu Hwang  ;  JiHyun Lee  ;  Hamid Namini  ;  William L. Heyward 
Citation
 Vaccine, Vol.30(16) : 2689-2696, 2012 
Journal Title
 Vaccine 
ISSN
 0264-410X 
Issue Date
2012
Abstract
Adults 40 years of age and older have been shown to be hypo-responsive immunologically to the currently available hepatitis B virus (HBV) vaccines. Three intramuscular doses of a Toll-like receptor 9 agonist, 1018 immunostimulatory sequence (1018 ISS) adjuvant, combined with recombinant hepatitis B surface antigen (HBsAg) demonstrated faster, superior, and more durable seroprotection than three doses of a licensed comparator HBV vaccine (Engerix-B(®)). This investigational vaccine, HBsAg-1018 ISS, was well tolerated with a safety profile similar to the comparator vaccine. These results suggest that HBsAg-1018 may be more effective in this hypo-responsive population
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/92001
Full Text
http://www.sciencedirect.com/science/article/pii/S0264410X1200165X
DOI
10.1016/j.vaccine.2012.02.001
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실)
Yonsei Authors
안상훈(Ahn, Sang Hoon)
Export
RIS (EndNote)
XLS (Excel)
XML
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse